Tirzepatide
Dual GIP/GLP-1 receptor agonist · research material
ALO-P-002-10MG · In stock
Ordering 10+ vials of Tirzepatide? 10+ vials of one compound are 40% off that compound, and 50+ vials are 50% off the whole order — confirmed on your order before payment.
For laboratory research use only. Not for human or veterinary use. Not a drug, food, supplement or cosmetic, and not intended to diagnose, treat, cure or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
- Lot number printed on every vial
- Each lot gets its own public record
- Purity by RP-HPLC, identity by mass spec
- Volume pricing from 10 vials
Tirzepatide is a dual-incretin research peptide engaging both GIP and GLP-1 receptor pathways, supplied lyophilized for laboratory study. Each lot carries its own analytical documentation — the exact record for the vial in hand is retrievable by lot ID in the COA directory.
For comparative dual-agonist receptor studies and downstream incretin-signaling models in qualified research settings.
- Catalog code
- ALO-P-002
- Form
- Lyophilized powder
- Molecular formula
- C225H348N48O68
- Molecular weight
- 4813.5 g/mol
- Classification
- Research peptide — laboratory use only
Store lyophilized at −20°C. Protect from light and moisture.
Handle using standard laboratory PPE and aseptic technique. Reconstitute only under controlled research conditions.
Laboratory handling guide →Sold strictly for in-vitro laboratory research by qualified purchasers aged 21 or older. We don’t provide dosing, administration or human-use guidance.
Read the research-use policy →
